Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use BUTRANS® safely and effectively. See full prescribing information for BUTRANS. BUTRANS® (buprenorphine) transdermal system, CIIIInitial U.S. Approval: 1981
Medication labelWhy this: Advisory · dailymed-prescription
BUTRANS is indicated for the management of severe and persistent pain that requires an opioid analgesic and that cannot be adequately treated with alternative options, including immediate-release opioids. Limitations of Use Because of the risks of addiction, abuse, misuse, overdose, and death, which can occur at any dosage or duration and persist over the course of therapy [see Warnings and Precautions (5.1)], reserve opioid analgesics, including BUTRANS, for use in patients for whom alternative treatment options are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. BUTRANS is not indicated as an as-needed (prn) analgesic.
- generic_name
- buprenorphine
- product_names
- buprenorphine
- ndc
- 59011-757, 59011-750, 59011-752, 59011-751, 59011-758, 59011-751-04, 59011-758-04, 59011-752-04, 59011-750-04, 59011-757-04
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en